These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 23235155)

  • 21. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
    Gripentrog JM; Miettinen HM
    Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis for activation and biased signaling at the thrombin-activated GPCR proteinase activated receptor-4 (PAR4).
    Thibeault PE; LeSarge JC; Arends D; Fernandes M; Chidiac P; Stathopulos PB; Luyt LG; Ramachandran R
    J Biol Chem; 2020 Feb; 295(8):2520-2540. PubMed ID: 31892516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling.
    Alvarez-Curto E; Inoue A; Jenkins L; Raihan SZ; Prihandoko R; Tobin AB; Milligan G
    J Biol Chem; 2016 Dec; 291(53):27147-27159. PubMed ID: 27852822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-arrestin-dependent PI(4,5)P
    Jung SR; Jiang Y; Seo JB; Chiu DT; Hille B; Koh DS
    Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33879605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor receptor-1 can function through a G alpha q/11-beta-arrestin-1 signaling complex.
    Kawamata Y; Imamura T; Babendure JL; Lu JC; Yoshizaki T; Olefsky JM
    J Biol Chem; 2007 Sep; 282(39):28549-28556. PubMed ID: 17664271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation.
    McLaughlin NJ; Banerjee A; Kelher MR; Gamboni-Robertson F; Hamiel C; Sheppard FR; Moore EE; Silliman CC
    J Immunol; 2006 Jun; 176(11):7039-50. PubMed ID: 16709866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
    Wei H; Ahn S; Barnes WG; Lefkowitz RJ
    J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The intracellular carboxyl tail of the PAR-2 receptor controls intracellular signaling and cell death.
    Zhu Z; Stricker R; Li Ry; Zündorf G; Reiser G
    Cell Tissue Res; 2015 Mar; 359(3):817-27. PubMed ID: 25519044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formyl peptide receptor-mediated ERK1/2 activation occurs through G(i) and is not dependent on beta-arrestin1/2.
    Gripentrog JM; Miettinen HM
    Cell Signal; 2008 Feb; 20(2):424-31. PubMed ID: 18060741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation.
    Coffa S; Breitman M; Hanson SM; Callaway K; Kook S; Dalby KN; Gurevich VV
    PLoS One; 2011; 6(12):e28723. PubMed ID: 22174878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta-Arrestins scaffold cofilin with chronophin to direct localized actin filament severing and membrane protrusions downstream of protease-activated receptor-2.
    Zoudilova M; Min J; Richards HL; Carter D; Huang T; DeFea KA
    J Biol Chem; 2010 May; 285(19):14318-29. PubMed ID: 20207744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation of class IA phosphoinositide 3-kinase catalytic subunits p110 alpha and beta by protease-activated receptor 2 and beta-arrestins.
    Wang P; Kumar P; Wang C; Defea KA
    Biochem J; 2007 Dec; 408(2):221-30. PubMed ID: 17680774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biased Gs versus Gq proteins and β-arrestin signaling in the NK1 receptor determined by interactions in the water hydrogen bond network.
    Valentin-Hansen L; Frimurer TM; Mokrosinski J; Holliday ND; Schwartz TW
    J Biol Chem; 2015 Oct; 290(40):24495-508. PubMed ID: 26269596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carboxy-Terminal Phosphoregulation of the Long Splice Isoform of Free-Fatty Acid Receptor-4 Mediates
    Senatorov IS; Cheshmehkani A; Burns RN; Singh K; Moniri NH
    Mol Pharmacol; 2020 May; 97(5):304-313. PubMed ID: 32132133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational analysis of the conserved Asp2.50 and ERY motif reveals signaling bias of the urotensin II receptor.
    Proulx CD; Holleran BJ; Boucard AA; Escher E; Guillemette G; Leduc R
    Mol Pharmacol; 2008 Sep; 74(3):552-61. PubMed ID: 18509066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. G-protein-coupled receptor kinase specificity for beta-arrestin recruitment to the beta2-adrenergic receptor revealed by fluorescence resonance energy transfer.
    Violin JD; Ren XR; Lefkowitz RJ
    J Biol Chem; 2006 Jul; 281(29):20577-88. PubMed ID: 16687412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.
    Tohgo A; Choy EW; Gesty-Palmer D; Pierce KL; Laporte S; Oakley RH; Caron MG; Lefkowitz RJ; Luttrell LM
    J Biol Chem; 2003 Feb; 278(8):6258-67. PubMed ID: 12473660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric modulation of M1 muscarinic acetylcholine receptor internalization and subcellular trafficking.
    Yeatman HR; Lane JR; Choy KH; Lambert NA; Sexton PM; Christopoulos A; Canals M
    J Biol Chem; 2014 May; 289(22):15856-66. PubMed ID: 24753247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7.
    Kohout TA; Nicholas SL; Perry SJ; Reinhart G; Junger S; Struthers RS
    J Biol Chem; 2004 May; 279(22):23214-22. PubMed ID: 15054093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2.
    Ge L; Shenoy SK; Lefkowitz RJ; DeFea K
    J Biol Chem; 2004 Dec; 279(53):55419-24. PubMed ID: 15489220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.